Skip to content

Clinical trials

Completed Phase 1/2 trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Completed Country / region: Singapore Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20065
20071
20084
20095
20104
20126
20133
20145
20152
20162
20171
20192
20202
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Singapore General Hospital5
Alachua Government Services, Inc.3
Bristol-Myers Squibb3
National University Hospital, Singapore3
Arcturus Therapeutics, Inc.2
Hoffmann-La Roche2
Merck KGaA, Darmstadt, Germany2
Pfizer2
AVEO Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular7
Carcinoma, Non-Small-Cell Lung6
Myelodysplastic Syndromes4
Colorectal Neoplasms3
Leukemia, Myeloid, Acute3
Liver Neoplasms3
Lymphoma, Non-Hodgkin3
Neoplasm Metastasis3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Breast Neoplasms2

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.